BIOLOGICS RARE AND ORPHAN CARE
Live / Registered — Registered (as of 15 Feb 2022)
What this means for you
Registered since 15 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90482182
- Registration number
- 6648633
- Mark type
- Stylized text
- Filed
- 22 Jan 2021
- Registered
- 15 Feb 2022
- Attorney of record
- Auma N. Reggy
Goods and services
- Class 044 — Medical, beauty and agricultural services: Dispensing of pharmaceuticals in the rare and orphan therapeutic areas; providing pharmaceutical advice in the field of delivery of oncology and rare and orphan drugs; medical counseling, namely, counseling for patients with cancer and other rare and orphan conditions to ensure safety and compliance in taking oncology and other highly complex rare specialty drugs; dispensing of pharmaceuticals in oncology and other rare and orphan therapeutic fields; dispensing of medications; consulting services in the field of health provided to clinicians, biopharma, life science companies, researchers and payors to help monitor and achieve positive outcomes for patients
- Class 045 — Legal and security services: Providing patient case management assistance services, namely, coordinating the procurement and administration of complex and high-cost rare and orphan specialty medications
Owner
- McKesson Corporation, Irving, TX, US
- McKesson Corporation, Irving, TX, US
Prosecution history
- 15 Feb 2022 — REGISTERED-SUPPLEMENTAL REGISTER
- 12 Jan 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Jan 2022 — ASSIGNED TO LIE
- 11 Jan 2022 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 11 Jan 2022 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 08 Jan 2022 — USE AMENDMENT ACCEPTED
- 20 Nov 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Nov 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Nov 2021 — AMENDMENT TO USE PROCESSING COMPLETE
- 20 Nov 2021 — USE AMENDMENT FILED
- 19 Nov 2021 — TEAS AMENDMENT OF USE RECEIVED
- 19 May 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 May 2021 — NON-FINAL ACTION E-MAILED
- 19 May 2021 — NON-FINAL ACTION WRITTEN